McIlrath & Eck’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
McIlrath & Eck's EXEL Position: Q1 2026 in Review
McIlrath & Eck increased its Exelixis (EXEL) stake by 269% in Q1 2026, buying an estimated $14.2K and bringing the position to 454 shares worth $19.5K. The position accounts for ﹤0.01% of the portfolio, ranked #828.
McIlrath & Eck first reported a position in EXEL in Q1 2025 and has held it in 3 quarters since. The position peaked at $52.4K in Q1 2025. 701 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.
- McIlrath & Eck held 454 shares of Exelixis worth $19.5K as of Q1 2026.
- McIlrath & Eck bought 331 Exelixis shares in Q1 2026, an estimated $14.2K.
- Exelixis made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #828 holding.
- McIlrath & Eck first reported a position in Exelixis in Q1 2025 and has held it in 3 quarters since.
- McIlrath & Eck's Exelixis position peaked at $52.4K in Q1 2025.
- 701 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.
Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.